v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Cash flows from operating activities    
Net income (loss) $ 58,614 $ (20,971)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 16,514 7,483
Amortization of deferred contract acquisition costs 52,193 44,165
Net accretion on marketable securities (933) (6,962)
Stock-based compensation expense 98,272 154,367
Charitable donation of Class A common stock 3,015 4,187
Non-cash operating lease expense 8,661 8,691
Provision for (benefit from) deferred income taxes 27,929 (360)
Change in fair value of contingent consideration 3,271 0
Other non-cash (credits) charges, net (6,379) 3,940
Changes in operating assets and liabilities:    
Accounts receivable 181,209 192,404
Contract assets (40,280) (23,514)
Deferred contract acquisition costs (67,984) (36,302)
Prepaid expenses and other assets (12,165) (21,151)
Accounts payable 6,857 (11,706)
Accrued expenses and other liabilities (34,917) 37,841
Accrued compensation and employee benefits (31,989) (51,354)
Operating lease liabilities, net (9,100) (6,412)
Deferred revenue (90,161) (113,757)
Net cash provided by operating activities 162,627 160,589
Cash flows from investing activities    
Purchases of marketable securities (309,441) (300,059)
Maturities of marketable securities 329,233 257,134
Purchases of property and equipment (4,073) (12,832)
Payments related to business acquisitions, net of cash acquired (149,403) (24,821)
Other investing, net 5,119 0
Net cash used in investing activities (128,565) (80,578)
Cash flows from financing activities    
Repurchases of Class A common stock (268,548) (329,101)
Proceeds from exercise of stock options 691 523
Payments of tax withholdings on settlement of equity awards (23,153) (26,297)
Proceeds from employee stock purchase plan contributions 7,359 8,069
Payments of deferred or contingent consideration related to business acquisitions (3,473) 0
Net cash used in financing activities (287,124) (346,806)
Effect of exchange rate changes (9,644) 16,216
Net decrease in cash, cash equivalents, and restricted cash (262,706) (250,579)
Cash, cash equivalents, and restricted cash - beginning of period 871,595 879,634
Cash, cash equivalents, and restricted cash - end of period 608,889 629,055
Supplemental disclosure of cash flow information    
Cash paid for income taxes, net 14,209 11,127
Supplemental disclosure of non-cash investing and financing activities    
Property and equipment purchases included in accounts payable 60 62
Contingent and deferred consideration recognized in connection with business acquisitions 29,567 9,835
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid $ 3,014 $ 4,852